IL17A and psoriasis: The infiltrating leukocytes in psoriasis patients release growth factors, cytokines, and chemokines such as VEGF, TNF-α, IL-17, IL-22, CXCL8, and CXCL2, affecting the proliferation and differentiation of epidermal keratinocytes, thus leading to the onset of disease.